Health Canada is currently consulting on a new regulatory pathway for non-prescription health products containing cannabidiol (CBD) — CHTA has submitted their views and invite you to review their response.
This is a critical step toward finally allowing safe, effective, CBD-containing natural health products, non-prescription drugs, and veterinary products to be sold in open retail markets, outside of Cannabis Act restrictions.